Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7324
    +0.0001 (+0.01%)
     

  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     

  • Bitcoin CAD

    87,938.52
    +184.74 (+0.21%)
     

  • CMC Crypto 200

    1,394.32
    +11.75 (+0.85%)
     

  • GOLD FUTURES

    2,347.70
    +5.20 (+0.22%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,771.75
    +204.25 (+1.16%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,813.01
    +184.53 (+0.49%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

OncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

CapitalCube
Updated
OncoGenex Pharmaceuticals, Inc. :OGXI-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

Categories: Yahoo Finance Get free summary analysis OncoGenex Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of OncoGenex Pharmaceuticals, Inc. – Immunomedics, Inc., Exelixis, Inc., Celgene Corporation, Ionis Pharmaceuticals, Inc., Bovie Medical Corporation, Teva Pharmaceutical Industries Limited Sponsored ADR, Eli Lilly and Company and Seattle ... Read more (Read more...)

Continue reading